Results 211 to 220 of about 16,949,019 (383)
DIFFERENTIATION OF POPULATION INCOME AND ECONOMIC GROWTH IN UKRAINE
, 2019 Anna Nahorna, Larissa Nikolenko
openalex +1 more source
The impact of population growth and climate change on food security in Africa: looking ahead to 2050
, 2017 C. Hall +4 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Root contraction does not increase long-term population growth in <i>Pediocactus bradyi</i>, an endangered cactus of Northern Arizona. [PDF]
AoB PlantsRojas-Pimentel J +2 more
europepmc +1 more source
Solving the stochastic dynamics of population growth. [PDF]
Ecol Evol, 2023 Marrec L, Bank C, Bertrand T.
europepmc +1 more source
Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma
Molecular Oncology, EarlyView.PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga +2 more
wiley +1 more source
Mapping the mismatch between building and population growth: A global study of 1,700 cities. [PDF]
iScienceLou S, Huang Y, Zou Y, Xia D.
europepmc +1 more source
Trade‐offs between phlorotannin production and annual growth in natural populations of the brown seaweedAscophyllum nodosum [PDF]
, 1999 Henrik Pavia +2 more
openalex +1 more source
Molecular Oncology, EarlyView.Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source